Cargando…
Integrating HECW1 expression into the clinical indicators exhibits high accuracy in assessing the prognosis of patients with clear cell renal cell carcinoma
BACKGROUND: Although many intratumoral biomarkers have been reported to predict clear cell renal cell carcinoma (ccRCC) patient prognosis, combining intratumoral and clinical indicators could predict ccRCC prognosis more accurately than any of these markers alone. This study mainly examined the prog...
Autores principales: | Wang, Chao, Dong, Keqin, Wang, Yuning, Peng, Guang, Song, Xu, Yu, Yongwei, Shen, Pei, Cui, Xingang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8335872/ https://www.ncbi.nlm.nih.gov/pubmed/34348693 http://dx.doi.org/10.1186/s12885-021-08631-9 |
Ejemplares similares
-
Integration of intratumoral RASSF10 expression and tumor-associated macrophages into the established clinical indicators better predicts the prognosis of clear cell renal cell carcinoma patients
por: Wang, Chao, et al.
Publicado: (2020) -
FCER1G positively relates to macrophage infiltration in clear cell renal cell carcinoma and contributes to unfavorable prognosis by regulating tumor immunity
por: Dong, Keqin, et al.
Publicado: (2022) -
Mutations in HECW2 are associated with intellectual disability and epilepsy
por: Halvardson, Jonatan, et al.
Publicado: (2016) -
RNF43 is a novel tumor-suppressor and prognostic indicator in clear cell renal cell carcinoma
por: ZHU, DAWEI, et al.
Publicado: (2022) -
Blocking the autocrine regulatory loop of Gankyrin/STAT3/CCL24/CCR3 impairs the progression and pazopanib resistance of clear cell renal cell carcinoma
por: Wang, Chao, et al.
Publicado: (2020)